Serum calprotectin is useful to confirm Inflammatory Bowel Disease activity but is not effective to predict relapse

被引：0
|
作者：
Veyrard, P. [1 ]
Roblin, X. [1 ]
Mao, R. [2 ]
Nancey, S. [3 ]
Waeckel, L. [4 ]
Berger, A. E. [4 ]
Williet, N. [5 ]
Bastide, L. [5 ]
Barrau, M. [5 ]
Tournier, Q. [5 ]
Paul, S. [4 ]
机构：
[1] CHU ST ETIENNE, Gastro Enterol, St Priest En Jarez, France
[2] Hosp Sun Yat Sen Univ, Inflammat & Immun, Guangzhou, Peoples R China
[3] Chu Lyon Sud, Gastroenterol, Lyon, France
[4] Chu St Etienne, Immunol, St Etienne, France
[5] CHU St Etienne, Gastroenterol, St Etienne, France
来源：
JOURNAL OF CROHNS & COLITIS | 2022年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P249
引用
收藏
页码：I294 / I294
页数：1
相关论文
共 50 条
  • [1] Can calprotectin predict relapse risk in inflammatory bowel disease?
    D'Incà, R
    Dal Pont, E
    Di Leo, V
    Benazzato, L
    Ferronato, A
    Padovan, K
    Sturniolo, GC
    GASTROENTEROLOGY, 2005, 128 (04) : A307 - A307
  • [2] Can calprotectin predict relapse risk in inflammatory bowel disease?
    D'Inca, Renata
    Dal Pont, Elisabetta
    Di Leo, Vincenza
    Benazzato, Luca
    Martinato, Matteo
    Lamboglia, Francesca
    Oliva, Lydia
    Sturniolo, Giacomo Carlo
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 (08): : 2007 - 2014
  • [3] Fecal calprotectin is useful in predicting disease relapse in pediatric inflammatory bowel disease
    Walkiewicz, Dorota
    Werlin, Steven L.
    Fish, Daryl
    Scanlon, Mathew
    Hanaway, Patrick
    Kugathasan, Subra
    INFLAMMATORY BOWEL DISEASES, 2008, 14 (05) : 669 - 673
  • [4] Can faecal calprotectin predict relapse in inflammatory bowel disease: a mini review
    Chew, T. S.
    Mansfield, J. C.
    FRONTLINE GASTROENTEROLOGY, 2018, 9 (01) : 23 - 28
  • [5] The use of serum calprotectin as a biomarker for inflammatory activity in inflammatory bowel disease
    Suarez Ferrer, Cristina
    Abadia Barno, Marta
    Martin Arranz, Eduardo
    Jochems, Andrea
    Garcia Ramirez, Laura
    Poza Cordon, Joaquin
    Jaquotot Herranz, Marta
    Cerpa Arencibia, Alberto
    Martin Arranz, Maria Dolores
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2019, 111 (10) : 744 - 749
  • [6] Accuracy of Consecutive Fecal Calprotectin Measurements to Predict Relapse in Inflammatory Bowel Disease Patients
    Dai, Cong
    Cao, Qin
    Jiang, Min
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2019, 53 (04) : 314 - 314
  • [7] Fecal Calprotectin Is a Useful Marker for Disease Activity in Pediatric Patients with Inflammatory Bowel Disease
    Tomoki Aomatsu
    Atsushi Yoden
    Kyoichi Matsumoto
    Emi Kimura
    Keisuke Inoue
    Akira Andoh
    Hiroshi Tamai
    Digestive Diseases and Sciences, 2011, 56 : 2372 - 2377
  • [8] Salivary Calprotectin is Not a Useful Biomarker to Monitor Disease Activity in Patients with Inflammatory Bowel Disease
    Bos, Vincent
    Crouwel, Femke
    Waaijenberg, Petra
    Bouma, Gerd
    Duijvestein, Marjolijn
    Buiter, Hans J. C.
    Brand, Henk S.
    Hamer, Henrike M.
    De Boer, Nanne K.
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2022, 31 (03) : 283 - 289
  • [9] Fecal Calprotectin Is a Useful Marker for Disease Activity in Pediatric Patients with Inflammatory Bowel Disease
    Aomatsu, Tomoki
    Yoden, Atsushi
    Matsumoto, Kyoichi
    Kimura, Emi
    Inoue, Keisuke
    Andoh, Akira
    Tamai, Hiroshi
    DIGESTIVE DISEASES AND SCIENCES, 2011, 56 (08) : 2372 - 2377
  • [10] Reply to: Accuracy of Consecutive Fecal Calprotectin Measurements to Predict Relapse in Inflammatory Bowel Disease Patients
    Ferreiro-Iglesias, Rocio
    Barreiro-de Acosta, Manuel
    Enrique Dominguez-Munoz, Juan
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2019, 53 (04) : 315 - 316
12345